Mark E Nance's Net Worth

$1.57 Million

Estimate Recalculated Nov 5, 2024 07:09PM EST

Who is Mark E Nance

Mark E Nance has an estimated net worth of $1.57 Million. This is based on reported shares across multiple companies, which include Envista Holdings Corp, and Insys Therapeutics, Inc..

SEC CIK

Mark E Nance's CIK is 0001755882

Past Insider Trading and Trends

2021 was Mark E Nance's most active year for acquiring shares with 9 total transactions. Mark E Nance's most active month to acquire stocks was the month of January. 2021 was Mark E Nance's most active year for disposing of shares, totalling 25 transactions. Mark E Nance's most active month to dispose stocks was the month of August. 2021 saw Mark E Nance paying a total of $575,314.68 for 64,975 shares, this is the most they've acquired in one year. In 2021 Mark E Nance cashed out on 41,625 shares for a total of $939,215.69, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Envista Holdings Corp

General Counsel
Updated Aug 27, 2024
Form 4
95.24K
Aug 27, 2024
95.24K
Grant
Aug 25
Form 4
-0.85%
-491.00
$15.94
-$7.83K
Jul 17, 2024
57.48K
Tax
Jul 15
Form 4
184.21%
71.92K
$22.65
-$58.89K
Feb 27, 2024
110.96K
Grant
Feb 25
Form 4
48.04%
1.50K
$23.74
$35.56K
Feb 05, 2024
4.62K
Grant
Feb 01
Form 4
14.69%
5.00K
$21.75
$108.75K
Nov 09, 2023
39.04K
Purchase
Nov 08
Form 4
-1.42%
-492.00
$35.07
-$17.25K
Jul 17, 2023
34.04K
Tax
Jul 15
Form 4
72.27%
1.31K
$38.73
$50.66K
Apr 06, 2023
3.12K
Grant
Apr 04
Form 4
100.11%
30.38K
$38.25
-$77.30K
Feb 28, 2023
60.72K
Grant
Feb 25
Form 4
-1.75%
-540.00
$38.79
-$20.95K
Jul 19, 2022
30.35K
Tax
Jul 15
Form 4
87.41%
24.37K
$48.52
-$79.43K
Mar 01, 2022
52.26K
Grant
Feb 25
Form 4
-8.66%
-4.32K
$35.53
-$73.27K
Sep 16, 2021
45.60K
Sale
ScheduledSep 14
Form 4
-1.93%
-980.00
$35.52
-$16.60K
Sep 07, 2021
49.92K
Sale
ScheduledSep 02
Form 4
-1.17%
-604.00
$35.56
-$10.28K
Aug 04, 2021
50.90K
Sale
ScheduledAug 02 - Aug 03
Form 4
-1.90%
-540.00
$41.91
-$22.63K
Jul 16, 2021
27.88K
Tax
Jul 15
Form 4
-14.30%
-14.26K
$35.39
-$247.07K
Jun 15, 2021
85.48K
Sale
ScheduledJun 11
Form 4
216.09%
43.09K
$37.94
-$28.42K
Feb 26, 2021
63.03K
Grant
Feb 25
Form 4
967.00
$35.54
$34.37K
Feb 17, 2021
967.00
Grant
Feb 12
Form 4
-2.64%
-540.00
$21.85
-$11.80K
Jul 17, 2020
19.94K
Tax
Jul 15
Form 4
580.11%
53.12K
Feb 26, 2020
62.27K
Grant
Feb 25
Form 4
38.68K
Dec 20, 2019
38.68K
Grant
Dec 18
Form 3
Sep 20, 2019
Showing 21 results

Insys Therapeutics, Inc.

Chief Legal Officer & Gen Cnsl
Updated Apr 23, 2019
Form 4
533.33%
80.00K
Apr 23, 2019
95.00K
Grant
Jan 25
Form 4
533.33%
80.00K
Apr 19, 2019
95.00K
Grant
Jan 25
Form 4
115.00K
Oct 12, 2018
115.00K
Grant
Oct 10
Form 3
Oct 12, 2018
Showing 4 results